deltatrials
Completed PHASE2 NCT00476424

A Pharmacokinetic Study of Once Daily Efavirenz 400 mg Versus 600 mg in Thai HIV-1 Infected Subjects

Sponsor: Ministry of Education, Thailand

Conditions HIV Infections
Interventions efavirenz
Updated 6 times since 2017 Last updated: Jul 15, 2020 Started: Jun 30, 2007 Primary completion: Mar 31, 2008 Completion: Mar 31, 2008

This PHASE2 trial investigates HIV Infections and is currently completed. Ministry of Education, Thailand leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jun 2018 — Aug 2020 [monthly]

    Completed PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2

    First recorded

Jun 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ministry of Education, Thailand
  • The HIV Netherlands Australia Thailand Research Collaboration
Data source: The HIV Netherlands Australia Thailand Research Collaboration

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Bangkok, Thailand